No headlines found.
SAB BIO to Participate in Upcoming Investor Conferences
Globe Newswire (Tue, 1-Sep 8:30 AM ET)
SAB BIO Reports Q2 2026 Financial Results and Provides Business Highlights
Globe Newswire (Thu, 6-Aug 7:30 AM ET)
Globe Newswire (Thu, 30-Jul 8:30 AM ET)
Breakthrough T1D Awards Grant to Support PRISE-hATG Study of SAB-142 in Stage 3 Type 1 Diabetes
Globe Newswire (Tue, 7-Jul 8:00 AM ET)
Sab Biotherapeutics - Warrant trades on the stock market under the symbol SABSW.
As of September 10, 2026, SABSW stock price was flat at $0.01 with 30,129 million shares trading.
SABSW has a beta of -0.94, meaning it tends to be less sensitive to market movements. SABSW has a correlation of 0.00 to the broad based SPY ETF.
SABSW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, SABSW traded as high as $.20 and as low as $.00.
SABSW has underperformed the market in the last year with a price return of -46.2% while the SPY ETF gained +17.7%. However, in the short term, SABSW had mixed performance relative to the market. It has outperformed in the last 3 months, returning +16.7% vs +3.1% return in SPY. But in the last 2 weeks, SABSW shares have been beat by the market, returning -49.1% compared to an SPY return of -1.1%.
SABSW support price is $.01 and resistance is $.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SABSW shares will trade within this expected range on the day.
